Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in Illinois | 1,017 Studies

Clinical Trials Breast CancerIllinois

Breast Cancer Clinical Trials in Illinois

Find 1,017 clinical trials for breast cancer near Illinois. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Illinois

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 141-160 of 1,017 trials

SuspendedEribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast CancerThis randomized phase III trial studies how well eribulin mesylate or paclitaxel work as first- or second-line therapy in treating patients with stage IIIC-IV breast cancer that…NCT02037529·Scottsdale, Arizona and 38 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedRandomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By ExemestaneTo compare the effects of exemestane for 5 years versus tamoxifen and exemestane given sequentially over 5 years in the adjuvant treatment of postmenopausal women with early…NCT00036270·Bessemer, Alabama and 178 others

Active not recruitingA Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 StudyThe purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy \[paclitaxel\] and avelumab in treating a type of breast…NCT04215146·Miami, Florida and 17 others

Active not recruitingTesting the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast CancerThis phase I/II trial studies the side effects and best dose of copanlisib and how well it works when given together with eribulin in treating patients with triple negative breast…NCT04345913·Sacramento, California and 42 others

TerminatedStudy of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase InhibitorsThe purpose of this study is to evaluate oral doses of BMS-754807 in combination with letrozole or BMS-754807 alone are safe and efficacious in locally advanced or metastatic…NCT01225172·Birmingham, Alabama and 20 others

Active not recruitingLow-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer SurvivorsEstrogen can cause the growth of breast cancer cells.NCT01196936·Birmingham, Alabama and 12 others

CompletedA Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast CancerThis is a Phase II, randomized, multicentre, multinational, open-label, cross-over study in adult patients who have completed neoadjuvant chemotherapy with neoadjuvant pertuzumab…NCT03674112·Lakewood, Colorado and 39 others

WithdrawnA Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast CancerThis Phase 1 study will assess the safety and efficacy (usefulness) of administering 2 doses of seasonal flu vaccine directly into breast cancer tissue (primary tumor), and will…NCT06229392·Chicago, Illinois

CompletedSafety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe NeutropeniaThe overall purpose of this study is to assess the dose response, efficacy, and safety of three different dose levels of AVI 014 (granulocyte colony-stimulating factor \[G-CSF\])…NCT00497809·Anaheim, California and 30 others

SuspendedTesting Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialThis phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive…NCT06671912·Anchorage, Alaska and 731 others

TerminatedAPRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)This study will compare the anti-tumor efficacy of apricoxib and lapatinib/capecitabine with placebo and lapatinib/capecitabine as measured by time to disease progression and…NCT00657137·Tucson, Arizona and 43 others

CompletedA Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast CancerTo demonstrate whether addition of MM-121 to paclitaxel is more effective than treatment with paclitaxel alone, when administered as part of the neoadjuvant treatment in Her2…NCT01421472·Birmingham, Alabama and 37 others

CompletedTopical Cryotherapy in Reducing Pain in Patients With Chemotherapy Induced Peripheral Neuropathy or Paclitaxel Induced Acute Pain SyndromeThis randomized pilot clinical trial studies topical cryotherapy (cooling hands and feet with ice bags) in reducing pain in patients with chemotherapy induced peripheral…NCT02640053·Urbana, Illinois and 7 others

Active not recruitingStudy of AB598 Monotherapy and Combination Therapy in Participants With Advanced CancersThe primary purpose of this study is to assess the safety and tolerability of AB598 in participants with advanced malignancies.NCT05891171·Phoenix, Arizona and 18 others

Active not recruitingComparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.The purpose of this study is to evaluate the efficacy of a new dose of 500 mg Fulvestrant with the standard dose of 250 mg in postmenopausal women with oestrogen receptor positive…NCT00099437·Casa Grande, Arizona and 105 others

CompletedStudy of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast CancerThe primary objective of this study is to assess and compare the efficacy and safety of sacituzumab govitecan-hzi versus treatment of physician's choice (TPC) in participants with…NCT03901339·Avondale, Arizona and 112 others

CompletedSWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical TrialRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002900·Mobile, Alabama and 104 others

CompletedStereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerThis phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating patients with breast cancer, non-small cell lung cancer, or…NCT02206334·Birmingham, Alabama and 77 others

CompletedA Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast CancerThis study will compare the cancer response to both treatments for locally advanced or metastatic breast cancerNCT00320541·Fayetteville, Arkansas and 31 others

CompletedCognition in the Study of Tamoxifen and RaloxifeneThe purpose of this study is to assess the effects of tamoxifen and raloxifene on cognitive aging in selected cognitively-healthy women.NCT00687102·Phoenix, Arizona and 133 others

PreviousPage 8 of 51Next

Other Conditions in Illinois

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma